BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16197293)

  • 1. Hyperhomocysteinaemia in chronic kidney disease: focus on transmethylation.
    van Guldener C; Stam F; Stehouwer CD
    Clin Chem Lab Med; 2005; 43(10):1026-31. PubMed ID: 16197293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine.
    Stam F; van Guldener C; ter Wee PM; Kulik W; Smith DE; Jakobs C; Stehouwer CD; de Meer K
    Am J Physiol Renal Physiol; 2004 Aug; 287(2):F215-23. PubMed ID: 15271686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease.
    Stam F; van Guldener C; Ter Wee PM; Jakobs C; de Meer K; Stehouwer CD
    Kidney Int; 2005 Jan; 67(1):259-64. PubMed ID: 15610249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental hyperhomocysteinaemia: differences in tissue metabolites between homocystine and methionine feeding in a rat model.
    Pexa A; Herrmann M; Taban-Shomal O; Henle T; Deussen A
    Acta Physiol (Oxf); 2009 Sep; 197(1):27-34. PubMed ID: 19254287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid treatment increases homocysteine remethylation and methionine transmethylation in healthy subjects.
    Stam F; Smulders YM; van Guldener C; Jakobs C; Stehouwer CD; de Meer K
    Clin Sci (Lond); 2005 May; 108(5):449-56. PubMed ID: 15647003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: implications for mechanism.
    Perna AF; Castaldo P; De Santo NG; di Carlo E; Cimmino A; Galletti P; Zappia V; Ingrosso D
    Kidney Int; 2001 Jun; 59(6):2299-308. PubMed ID: 11380834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of transmethylation disturbs neurulation in chick embryos.
    Afman LA; Blom HJ; Drittij MJ; Brouns MR; van Straaten HW
    Brain Res Dev Brain Res; 2005 Aug; 158(1-2):59-65. PubMed ID: 15996755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic consequences of hyperhomocysteinemia in uremia.
    Perna AF; Ingrosso D; Satta E; Romano M; Cimmino A; Galletti P; Zappia V; De Santo NG
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S85-90. PubMed ID: 11576929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
    Green TJ; Skeaff CM; McMahon JA; Venn BJ; Williams SM; Devlin AM; Innis SM
    Br J Nutr; 2010 Jun; 103(11):1629-34. PubMed ID: 20089204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue levels of S-adenosylhomocysteine in the rat kidney: effects of ischemia and homocysteine.
    Kloor D; Delabar U; Mühlbauer B; Luippold G; Osswald H
    Biochem Pharmacol; 2002 Feb; 63(4):809-15. PubMed ID: 11992651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperhomocysteinemia in chronic renal failure.].
    Satta E; Perna AF; Lombardi C; Acanfora F; Violetti E; Romano MM; Capasso R; Pisano M; Paduano F; De Santo NG
    G Ital Nefrol; 2006; 23(5):480-9. PubMed ID: 17123261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine and methionine metabolism in renal failure.
    van Guldener C; Stehouwer CD
    Semin Vasc Med; 2005 May; 5(2):201-8. PubMed ID: 16047272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia.
    Ingrosso D; Cimmino A; Perna AF; Masella L; De Santo NG; De Bonis ML; Vacca M; D'Esposito M; D'Urso M; Galletti P; Zappia V
    Lancet; 2003 May; 361(9370):1693-9. PubMed ID: 12767735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients.
    Herrmann W; Obeid R
    Clin Chem Lab Med; 2005; 43(10):1039-47. PubMed ID: 16197295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease.
    Castro R; Rivera I; Struys EA; Jansen EE; Ravasco P; Camilo ME; Blom HJ; Jakobs C; Tavares de Almeida I
    Clin Chem; 2003 Aug; 49(8):1292-6. PubMed ID: 12881445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative evaluation and regulation of S-adenosylmethionine-dependent transmethylation in sheep tissues.
    Xue GP; Snoswell AM
    Comp Biochem Physiol B; 1986; 85(3):601-8. PubMed ID: 3791961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine and methionine metabolism in ESRD: A stable isotope study.
    van Guldener C; Kulik W; Berger R; Dijkstra DA; Jakobs C; Reijngoud DJ; Donker AJ; Stehouwer CD; De Meer K
    Kidney Int; 1999 Sep; 56(3):1064-71. PubMed ID: 10469375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of S-adenosylhomocysteine in cardiovascular disease and its potential epigenetic mechanism.
    Xiao Y; Su X; Huang W; Zhang J; Peng C; Huang H; Wu X; Huang H; Xia M; Ling W
    Int J Biochem Cell Biol; 2015 Oct; 67():158-66. PubMed ID: 26117455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired transmethylation potential in Parkinson's disease patients treated with L-Dopa.
    De Bonis ML; Tessitore A; Pellecchia MT; Longo K; Salvatore A; Russo A; Ingrosso D; Zappia V; Barone P; Galletti P; Tedeschi G
    Neurosci Lett; 2010 Jan; 468(3):287-91. PubMed ID: 19909787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes of hyperhomocysteinemia in patients with chronic kidney diseases.
    Garibotto G; Sofia A; Valli A; Tarroni A; Di Martino M; Cappelli V; Aloisi F; Procopio V
    Semin Nephrol; 2006 Jan; 26(1):3-7. PubMed ID: 16412817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.